This document discusses standard operating procedures (SOPs) at Grifols, a pharmaceutical company that produces plasma-derived medications. It contains the following key points:
1) Grifols has written SOPs that provide guidance for every task and are derived from regulations like the Code of Federal Regulations and EU Guidelines. SOPs ensure safety and quality.
2) The CFR requires that SOPs include procedures for donor eligibility, equipment calibration, sterilization methods, quality control, and other production steps.
3) Strict adherence to SOPs and documentation is required at every stage of production from donor screening to distribution to ensure plasma-derived medications meet quality standards.